Despite enormous progress and development of high-throughput methods in genome-wide mRNA analyses, data on the erythroid transcriptome are still limited, even though they could be useful in medical diagnostics and personalized therapy as well as in research on normal and pathological erythroid maturation. Although obtaining normal and pathological reticulocyte transcriptome profiles should contribute greatly to our understanding of the molecular bases of terminal erythroid differentiation as well as the mechanisms of the hematological diseases, a basic limitation of these studies is the difficulty of efficient reticulocyte RNA isolation from human peripheral blood. The restricted number of possible parallel experiments primarily concern healthy individuals with the lowest number of reticulocytes in the peripheral blood and a low RNA content. In the present study, an efficient method for reticulocyte RNA isolation from healthy individuals and hemolytic anaemia patients is presented.
| INTRODUCTION
Reticulocytes are non-nucleated immature red blood cells in peripheral blood of mammalian species. Young cells contain residual RNA and micro-organelles such as ribosomes, lysosomes, and mitochondria. The residual RNA is not only functional, but also necessary for the final stages of reticulocyte maturation. 1, 2 Transformation from a reticulocyte to a fully mature red cell is a complex process requiring substantial remodelling of the erythrocytic cytoplasm and membrane. 3 Maturation of the reticulocyte is a 2-3-day-long process, during which hemoglobin synthesis occurs, and during the last days old reticulocytes eliminate their residual RNA and are released into the circulation, to become mature red blood cells. 4 The presence of an intracellular network of residual reticulocyte RNA allows one to differentiate between various stages of the development of reticulocytes. The detection of reticulocyte RNA with brilliant cresyl blue allows one to distinguish reticulocytes from mature red blood cells as well as enabling the identification of the youngest, highly fluorescent reticulocytes (HFR), supplied early from bone marrow in conditions of increased erythropoietic stimulation, eg, hemolytic anaemia.
An example of such conditions is increased hemolysis due to red blood cell pathology. Importantly, in hemolytic anaemia both HFR and the reticulocyte count are markedly increased and inversely correlated with hemoglobin (Hb) level. 5 Hence, reticulocytes (as well as their transcriptome) may be useful in the diagnostics of hematopoietic system diseases including hemolytic anaemia.
Adult peripheral blood is characterized by a low reticulocyte count resulting in an extremely low yield of reticulocyte RNA isolation as compared to cord blood. 6 Therefore, few parallel experiments on healthy individuals' reticulocytes are possible due to having the lowest number of reticulocytes in their peripheral blood.
Furthermore, although reticulocyte transcriptome analyses could greatly improve our understanding of reticulocytes' maturation, they require relatively high quality of reticulocyte RNA free of RNA derived from other blood cells. Only few procedures for peripheral blood reticulocyte isolation are available in the literature. 7, 8 Taken together, developing novel efficient methods for quality reticulocyte RNA isolation constitutes an essential step in further studies on their maturation.
Herein we propose a novel, simple, and effective method for the isolation of reticulocyte RNA from both healthy individuals and hemolytic anaemia patients. The method was validated on blood samples obtained from Polish individuals who were adult males (aged 25-40 years): (a) three healthy individuals (including one blood donor), (b) one hereditary spherocytosis (HS) patient [9] [10] [11] and (c) two hereditary nonspherocytic hemolytic anaemia (HA) patients (brothers). The four-step reticulocyte isolation procedure presented here can be performed within a few hours of blood donation, as recommended by RNA isolation procedures. Finally, the proposed method allows efficient and specific isolation of reticulocyte RNA, which can be successfully used for detection of specific transcripts by both qPCR and RNA-Seq (RNA sequencing). 
| Flow cytometry phenotyping
Flow cytometric analysis was performed using a BD FACSCalibur flow cytometer to ensure the purity of the isolated CD71 + cells.
Packed reticulocytes were directly stained with anti-human CD71-PE antibody (Miltenyi Biotec, Bergisch-Gladbach, Germany) to identify the different reticulocyte populations relative to RNA content as measured by Thiazole Orange (TO). Thiazole Orange (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in methanol to obtain a 1 mg/mL TO stock solution. The stock solution was kept at −20°C in darkness.
A TO working solution (20 μg/mL) was prepared by adding 6 μL of stock solution to 30 mL of PBS (pH 7.4).
Samples were stained as follow: 1.3 μL of peripheral blood (or 3 μL of isolated reticulocytes sample) was added to 2.5 mL of TO working solution containing 6 μL of anti-CD71-PE antibody (Miltenyi Biotec) or 6 μL of an isotype control (Mouse IgG2a-PE; Miltenyi Biotec). After 20 minutes incubation samples were analysed. The FL-1 channel (BP 530/30) was employed to detect TO fluorescence whereas the FL-2 channel (BP 585/42) was employed for PE fluorescence. Single stained samples were used for setting the correct fluorescence compensation.
| Purification of reticulocytes from human peripheral blood
The procedure of purification of reticulocytes from human peripheral blood included four steps ( Figure 1 ):
1. Fresh blood from volunteers and patients immediately after drawing was diluted with PBS-EDTA pH 7.4 buffer (27 mL: 70 mL) and was passed through a LEUCOBED LCG3 filter (Macopharma, London, UK) to remove most leukocytes and platelets. 
| RNA isolation and cDNA synthesis
Total RNA was extracted from the reticulocyte-rich suspension and collected using the miRNeasy Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer's recommendation. In the first isolation step,~0.4 mL of the reticulocyte-rich pellet with the supernatant was divided into two aliquots. In further steps we followed the manufacturer's procedure until the material was applied onto an RNeasy Mini Spin Column. During this step, the materials from two aliquots were pooled (to enhance yields of RNA isolation), to ensure fulfilling the minimal column capacity required for efficient RNA isolation. RNA concentrations were calculated based on the absorbance at 260 nm. RNA samples were stored at −70°C. The first strand of cDNA was synthesized using a RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, MA, USA).
| Assessment of purity of isolated reticulocyte population by RT-PCR
To verify the purity of the reticulocyte population the RNA isolates from reticulocyte populations was tested using specific primers for marker gene transcripts: HBB, PPARA, PTPRC, ITGB3, and ACTB. Primer sequences are listed in Supporting Information Table S2 . A twostep RT-PCR was applied (DreamTaq DNA Polymerase; Thermo Fisher Scientific).
| Next generation RNA sequencing analyses
Next generation sequencing was performed by Heflin Center for Genomic Science Core Laboratories, University of Alabama at Birmingham, AL, USA. Directly prior to the RNA-Seq procedure, the total F I G U R E 1 Scheme of four-step purification procedure used to obtain reticulocyte-rich suspension from human peripheral blood
RNA integrity was verified by on-chip electrophoresis (Bioanalyzer, Agilent Technologies, Santa Clara, CA, USA) and only samples with high RNA integrity (RIN) values were further processed (>7.5). In addition, quality score analysis was performed confirming the high quality of RNA samples. Following rRNA depletion, the remaining RNA fraction was used for library construction and subjected to 100 bp paired-end sequencing on an Illumina HiSeq 2000 instrument.
Sequencing reads were aligned to the human reference genome assembly (hg19) using TopHat. 12 Transcript assembly and estimation of the relative abundances were carried out with Cufflinks. GeneCards. When using GeneAnalytics we focus our analysis only on expression signatures that were assigned with high scores, which reflects high biological pathway/phenotype coverage. The gene nomenclature was adjusted to the webserver requirements (GeneCards).
3 | RESULTS
| Reticulocyte isolation
Fresh peripheral blood was collected from healthy volunteers, patients with hereditary spherocytosis and hemolytic anaemia. The mean age of the volunteers/patients (6 men) was 34 years (25-40).
Differences in the reticulocyte count in hemolytic anaemia patients and healthy individuals are shown in Figure 2A . To obtain a reticulocyte-rich population free of nucleated blood cells we applied a fourstep procedure ( Figure 1 , Section 2). In the first step, the whole blood was filtered through a leukocyte removal filter. Then the resulting blood filtrate was centrifuged on the Ficoll-Paque Premium density gradient followed by further purification of reticulocytes by
Percoll density gradient centrifugation. 16 The former step was repeated once to remove most of the red blood cells, as their presence prevented correct execution of the next steps. The abovementioned steps of the presented procedure were still not sufficient to obtain a pure reticulocyte population. Monocytes and platelets (which also contained RNA) were still present in our microscopic preparations. Hence, to remove the residual nucleated cells and platelets the MACS magnetic cell separation technology was applied.
Initially, a method of positive selection of reticulocytes with the CD71 MicroBeads was used. However, this approach was successful for patients with high reticulocytosis only. In healthy subjects, CD71 + cells were so scarce that no effective RNA isolation was possible. For this reason, we decided to use negative selection of leukocytes and platelets using CD61 and CD45 MicroBeads. The resulting reticulocyte preparation, although containing a reasonable number of red blood cells (Supporting Information Figure S1 ), provided a starting material for efficient RNA isolation in which a highly purified reticulocyte population is needed. An effective method to differentiate various stages of the development of reticulocytes is the use of Thiazole Orange (TO) staining, 17 which can be substituted for another commonly used reticulocyte classification system known as the reticulocyte maturity index (RMI). 18 The most effective method of determining the cord reticulocyte subset with minimal artifacts is the use of anti-CD71 antibodies and magnetic separation. 6 The CD71 positive group characterizes the early human reticulocytes (Heilmeyer groups I to III) and the mature CD71 negative subset (Heilmeyer group IV) which were found in normal circulation. 19 To analyse the maturity status and the number of reticulocytes, the sample was incubated with Thiazole Orange (TO) and CD71-PE markers and counted by flow cytometry (Figure 2B-D) . Results for each HA patient (N61 and N62) were compared independently to both controls (C1 and C14).
| RNA isolation and cDNA synthesis
In order to test the usefulness of the described procedure of reticulocyte purification the functional quality of RNA was tested. RNA isolation was carried out as described in the Section 2. The obtained RNA quantities were sufficient for RNA-Seq analysis for all study groups ( Figure 3 ). The amount of RNA obtained from patient C14 diagnosed with HS was relatively low despite the increased reticulocytosis, which in our opinion is a consequence of decreased osmotic resistance of the red blood cells/reticulocytes resulting in excessive hemolysis observed during the reticulocyte isolation procedure.
| Assessment of purity of isolated reticulocyte population by RT-PCR
The reliability of RNA-Seq analysis is based on obtaining a reticulocyte population free of contamination with other blood cells. Hence,
to assess the reticulocyte purity we tested the obtained RNA isolates for the presence of high-and low-abundant transcripts characteristic for these blood cells as well as for the absence of transcripts specific for platelets and leukocytes. As shown in Figure 4 and Supporting Information Figure S2 , the RNA obtained from the isolated reticulocyte population contained only the gene transcripts that were reticulocyte-specific: "high abundance" HBB, and "low abundance" PPARA (peroxisome proliferator-activated receptor alpha, by an example which was taken from the end of the reticulocyte cDNA library; NCBI, Library 11923). As a quantitative control β-actin (ACTB) primers were used. Furthermore, to verify efficient removal of leukocytes and platelets the RNA isolates from reticulocyte populations were tested. Transcripts specific markers for platelets (integrin β3 (ITGB3)) and for leukocytes (CD45 (PTPRC)) were absent.
| Next generation RNA sequencing analysesExpression status for erythroid and non-erythroid transcripts
Reticulocyte transcriptome analysis using high-efficiency gene expression assays was performed by RNA-Seq for four male subjects F I G U R E 3 RNA amounts for each examined group. Healthy individuals (n = 4), C14-hereditary spherocytosis patient and HAhemolytic anaemia patients (n = 2) Our reticulocyte transcriptome pattern was generated using the RNA-Seq method and Cufflinks tool, the most popular RNA-Seq analysis tool that assembles transcripts, estimates their abundances, and tests for differential expression and regulation in RNA-Seq samples. 13 Our analysis resulted in successful identification (positive reads status-number of reads allowing reliable location of its position in the nucleotide sequence) of 2685-2961 and 2465-2729 unique gene transcripts in healthy subjects and HS patient respectively. Importantly, among the identified gene transcripts the erythroid mRNAs were well represented, whereas non-erythroid transcripts were absent (Table 1) . These results indicate that the isolated population of reticulocytes is characterized by high homogeneity.
Using the GeneAnalytics web server, the results of RNA-Seq analysis were convincingly (high score) assigned to 111 metabolic pathways, 104 biological processes, 31 molecular function pathways, 75 diseases, and 22 phenotypes (Supporting Information Table S3 ).
Importantly, our set of gene transcripts was associated with 22 phenotypes that correlate with erythroid cells. anaemia associated with increased osmotic fragility including conditions such as hereditary spherocytosis or hereditary elliptocytosis are characterized by high reticulocytosis, but usually during the isolation procedure increased hemolysis occurs, which significantly reduces the efficiency of isolation. In our procedure, we tried to optimize the method, to minimize hemolysis. However, the most challenging aspect is achieving efficient separation of the reticulocytes from the peripheral blood of individuals with a normal reticulocyte count, which has been pointed out in some reports. 6 As mentioned above, in the peripheral blood of healthy individuals only the mature subset of CD71 negative reticulocytes is detected, whereas in patients with hemolytic anaemia, Importantly, the extended list of identified transcripts obtained in our study provided much better coverage of gene ontology terms, as reflected by higher scores. Furthermore, using the GeneAnalytics web server we identified in our transcript set of genes associated with 22 phenotypes, whereas microarray data analysis resulted in identification of transcripts associated with 19 phenotypes (Table 2) .
Importantly, the genes identified by RNA-Seq were associated specifically with erythroid phenotypes.
Taken together, gene ontology analysis supports the conclusion that the experimental approach proposed in this study provides an improved insight into biological processes that govern reticulocyte maturation, function and pathology. Undeniably, obtaining depth and reliable insight into related transcriptome profiles should significantly help to understand these mechanisms.
In conclusion, we have presented an efficient procedure of reticulocyte isolation from peripheral blood. This procedure should be useful in particular for normal, healthy individuals, whose blood is poor in reticulocytes, and for hemolytic anaemia patients including HS patients with increased hemolysis. This will increase the statisti- 
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